Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea

about

Cost-effectiveness of gefitinib, icotinib, and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China.Therapeutic Schedule Evaluation for Brain-Metastasized Non-Small Cell Lung Cancer with A Probabilistic Linguistic ELECTRE II Method

P2860

Q37706099-C4F57C91-CD1D-46B2-820F-A15AD091E54F Q58726051-5A57F0DC-6C8C-4E19-AEA8-B5890B8D838F

P2860

Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea

Item

http://www.wikidata.org/entity/Q36092393

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Economic Evaluation of Compani ...... Cancer Patients in South Korea

@ast

Economic Evaluation of Compani ...... Cancer Patients in South Korea

@en

type

Item

label

Economic Evaluation of Compani ...... Cancer Patients in South Korea

@ast

Economic Evaluation of Compani ...... Cancer Patients in South Korea

@en

prefLabel

Economic Evaluation of Compani ...... Cancer Patients in South Korea

@ast

Economic Evaluation of Compani ...... Cancer Patients in South Korea

@en

P1476

Economic Evaluation of Compani ...... Cancer Patients in South Korea

@en

P2093

Eun-A Lim

http://www.w3.org/2001/XMLSchema#string

Eunmi Bae

http://www.w3.org/2001/XMLSchema#string

Jaeok Lim

http://www.w3.org/2001/XMLSchema#string

Sang-Eun Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

A trial-based cost-effectiveness analysis of erlotinib alone versus platinum-based doublet chemotherapy as first-line therapy for Eastern Asian nonsquamous non-small-cell lung cancer

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients.

Pemetrexed plus platinum or gemcitabine plus platinum for advanced non-small cell lung cancer: final survival analysis from a multicentre randomized phase II trial in the East Asia region and a meta-analysis.

A randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line therapy for patients with locally advanced or metastatic non-small-cell lung cancer.

A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC).

Administrative and claims records as sources of health care cost data.

Correlation between EGFR mutation status and response to first-line platinum-based chemotherapy in patients with advanced non-small cell lung cancer.

P304

e0160155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0160155

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Young Kee Shin

Haeyoung Lee

P577

2016-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27483001

http://www.w3.org/2001/XMLSchema#string

P932

4970739

http://www.w3.org/2001/XMLSchema#string

Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea

about

P2860

P2860

Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932